Concepedia

Laxminarayan Rawat

LR

5

Publications

179

Citations

5

H-Index

2020

Active since

Affiliations

Birla Institute of Technology and Science, Pilani - Goa Campus(Current)

Birla Institute of Technology and Science, Pilani

Harvard University

Boston Children's Hospital

Laxminarayan Rawat is an author at Birla Institute of Technology and Science, Pilani - Goa Campus specializing in cancer research, tumor microenvironment, and medicine.

ORCID

Top concepts

Publications per year

2020–2024

5

Publications

5

Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells

Laxminarayan Rawat, Harsha V. Hegde, S. L. Hoti et al. · Biomedicine & Pharmacotherapy · 2020 · 91 citations · Full text

, , +10

Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy

Rahul Kumar, Harsh Goel, Raghu Solanki et al. · Medicine in Drug Discovery · 2024 · 31 citations · Full text

, , +23

A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress

Laxminarayan Rawat, Murugabaskar Balan, Yuzuru Sasamoto et al. · Redox Biology · 2023 · 23 citations · Full text

Ursolic acid disturbs ROS homeostasis and regulates survival-associated gene expression to induce apoptosis in intestinal cancer cells

Laxminarayan Rawat, Vijayashree Nayak · Toxicology Research · 2021 · 22 citations · Full text

Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells

Laxminarayan Rawat, Vijayashree Nayak · Chemico-Biological Interactions · 2022 · 12 citations

Rows per page

1–5 of 5